Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender Gap in Leadership of Clinical Trials.
Waldhorn I, Bomze D, Ben-Aharon I, Schlosser S, Markel G, Ludmir EB, Meirson T. Waldhorn I, et al. Among authors: ludmir eb. JAMA Intern Med. 2023 Dec 1;183(12):1406-1408. doi: 10.1001/jamainternmed.2023.5104. JAMA Intern Med. 2023. PMID: 37902723
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials.
Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR Jr, Ludmir EB. Florez MA, et al. Among authors: ludmir eb. JAMA Netw Open. 2023 May 1;6(5):e2313819. doi: 10.1001/jamanetworkopen.2023.13819. JAMA Netw Open. 2023. PMID: 37195664 Free PMC article. Clinical Trial.
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.
Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, Meirson T, Sun R, Ludmir EB. Sherry AD, et al. Among authors: ludmir eb. Eur J Cancer. 2023 Nov;194:113357. doi: 10.1016/j.ejca.2023.113357. Epub 2023 Sep 22. Eur J Cancer. 2023. PMID: 37827064 Free article.
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.
Hsu EJ, Lin TA, Dabush DR, McCaw Z, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Noticewala S, Yang Y, Sherry AD, Fuller CD, Thomas CR Jr, Tang C, Msaouel P, Das P, Huang B, Tian L, Sun R, Lee JJ, Meirson T, Ludmir EB. Hsu EJ, et al. Among authors: ludmir eb. J Natl Cancer Inst. 2024 Feb 9:djae028. doi: 10.1093/jnci/djae028. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 38331394
Highlighting the need for reliable clinical trials in glioblastoma.
Mandel JJ, Youssef M, Ludmir E, Yust-Katz S, Patel AJ, De Groot JF. Mandel JJ, et al. Expert Rev Anticancer Ther. 2018 Oct;18(10):1031-1040. doi: 10.1080/14737140.2018.1496824. Epub 2018 Jul 12. Expert Rev Anticancer Ther. 2018. PMID: 29973092 Review.
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR Jr, Fuller CD. Ludmir EB, et al. JAMA Oncol. 2019 Dec 1;5(12):1769-1773. doi: 10.1001/jamaoncol.2019.2055. JAMA Oncol. 2019. PMID: 31158272 Free PMC article.
175 results